Form 4/A for AEHR AEHR TEST SYSTEMS

Accepted 2022-10-20 00:00:00 ET · period of report 2022-07-14 · accession 0001654954-22-013962 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MA	2022-10-20	2022-07-14	AEHR	Erickson Gayn	Pres, CEO, Dir	A - Grant	$0.00	+151.5K	643.2K	+31%	$0
A	2022-10-20	2022-07-14	AEHR	Erickson Gayn	Pres, CEO, Dir	F - Tax	$8.00	-36.6K	675.5K	-5%	-$293.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-07-14	A	A	68,988	$0.00	712,154	D	—	—	(F2) Represents shares of common stock issued upon vesting of performance-based RSUs.
2	Common	Common Stock	2022-07-14	A	A	82,500	$0.00	643,166	D	—	—	(F1) This report on Form 4/A is being filed to correct the footnote 1 on form 4 originally filed on July 18, 2022. The correct footnote should state: One-sixteenth (1/16) of the 75,000 of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. One-sixteenth (1/16) of the 7,500 of shares subject to the restricted shares awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates.
3	Common	Common Stock	2022-07-14	F	D	36,630	$8.00	675,524	D	—	—	(F3) Represents shares that were withheld to satisfy tax withholding obligations upon vesting of performance-based RSUs described in footnote 2. This does not represent a sale by the Reporting Person. (F4) The amount reported includes shares subject to unvested restricted shares and restricted stock units.